New potential treatment pathway against diffuse large large B-cell lymphoma

Researchers from Weill Cornell Medical College believe they have discovered a new pathway for treatment of patients with diffuse large B-cell lymphoma (DLBCL), the most commonly diagnosed subtype of non-Hodgkin's lymphoma.

Current standard treatment for DLBCL includes combination chemotherapy in the form of R-CHOP followed by radiation, but this treatment carries a significant toxicity profile along with tissue damage and sometimes severe side effects. A more targeted treatment is therefore in order.

Patients with DLBCL often have tumors that express the BLC-6 gene mutation, offering these researchers a potential treatment pathway by using an inhibitor known as RI-BPI along with a histone deacetylases (HDAC) inhibitor or with a heat shock protein (Hsp90) inhibitor. When researchers exploited this pathway, they were able to stifle tumor activity and even wipe out any signs of cancer.

NOTE: These results are derived from pre-clinical (mouse model) trials and should therefore be considered accordingly.

TREATMENT TYPE(S)

Targeted treatment

WHERE WAS THIS STUDY PUBLISHED?

Journal of Clinical Investigation

More Articles

More Articles

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...

Secondary cancers are cancers that develop as a result of chemotherapy and/or...

One of the greatest fears of lymphoma survivors is that they’ll relapse and have to undergo treatment again. This fear is normal but awful to...

Over the years, various classification systems have been used to differentiate lymphoma types including the Rappaport Classification (used until...

If you are new to this website or are looking for guidance to a specific page, here is a list of links to articles that can help you. The "Main...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Advances in the treatment of Hodgkin's lymphoma have resulted in remarkable survival rates, even for...